D-Pharm grants Jiangsu NHWA exclusive rights to DP-VPA in China to treat epilepsy

D-Pharm Ltd.

Israel / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Jiangsu NHWA Pharmaceutical Co. Ltd.

China / Small-Cap Biopharma (<$1 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced